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Introduction
The ubiquitin–proteasome system accounts for a major por-
tion of eukaryotic protein degradation. Proteins destined for 
proteolysis by this pathway are covalently modified with 
chains of the protein ubiquitin through the sequential action 
of ubiquitin-activating enzymes (E1s), ubiquitin-conjugating 
enzymes (E2s), and ubiquitin ligases (E3s; Ciechanover et al., 
1980; Scheffner et al., 1995). Ubiquitylated substrates are 
degraded by the 26S proteasome (Ravid and Hochstrasser, 2008). 
In the yeast Saccharomyces cerevisiae, the transmembrane (TM) 
RING domain proteins Hrd1 and Doa10 are the predominant 
ER-associated degradation (ERAD) E3s that target misfolded 
and regulatory proteins for proteolysis (Hampton et al., 1996; 
Plemper et al., 1999; Wilhovsky et al., 2000; Bays et al., 2001; 
Swanson et al., 2001). With a few exceptions, Hrd1 and Doa10 
recognize unique substrate classes depending on degron dis-
position relative to the ER membrane (Vashist and Ng, 2004; 
Carvalho et al., 2006). Specifically, Hrd1 recognizes proteins 
with ER luminal or intramembrane degrons, called ERAD-L 
(lumen) and ERAD-M (membrane) substrates, respectively 
(Carvalho et al., 2006; Gauss et al., 2006; Sato et al., 2009). 
In contrast, Doa10 promotes degradation of proteins with cyto-
plasmically disposed degrons, ERAD-C (cytoplasm) substrates 
(Huyer et al., 2004; Ravid et al., 2006; Metzger et al., 2008). 
Hrd1 and Doa10 exhibit overlapping E2 requirements. Hrd1 
mediates ubiquitin transfer from Ubc7 and, to a lesser extent, 
Ubc1 (Plemper et al., 1999; Bays et al., 2001), whereas Doa10 
functions with Ubc6 and Ubc7 (Swanson et al., 2001).
The prototypical Doa10 substrate is the transcriptional 
repressor MAT2, the proteolytic control of which is critical 
for regulating the yeast-mating phenotype (Swanson et al., 
2001; Laney and Hochstrasser, 2003). The N-terminal 67 resi-
dues of MAT2, Deg1, contain a degron for Doa10-dependent 
degradation (Hochstrasser and Varshavsky, 1990; Johnson 
et al., 1998; Swanson et al., 2001). Importantly, Deg1 confers 
Doa10-dependent instability when fused to the cytoplasmic 
N termini of heterologous soluble proteins (Hochstrasser and 
Varshavsky, 1990; Chen et al., 1993; Johnson et al., 1998; 
Little is known about quality control of proteins that aberrantly or persistently engage the endoplasmic reticulum (ER)-localized translocon en route to mem-
brane localization or the secretory pathway. Hrd1 and 
Doa10, the primary ubiquitin ligases that function in 
ER-associated degradation (ERAD) in yeast, target dis-
tinct subsets of misfolded or otherwise abnormal proteins 
based primarily on degradation signal (degron) loca-
tion. We report the surprising observation that fusing 
Deg1, a cytoplasmic degron normally recognized by 
Doa10, to the Sec62 membrane protein rendered the 
protein a Hrd1 substrate. Hrd1-dependent degrada-
tion occurred when Deg1-Sec62 aberrantly engaged 
the Sec61 translocon channel and underwent topologi-
cal rearrangement. Mutations that prevent translocon 
engagement caused a reversion to Doa10-dependent 
degradation. Similarly, a variant of apolipoprotein B, 
a protein known to be cotranslocationally targeted for 
proteasomal degradation, was also a Hrd1 substrate. 
Hrd1 therefore likely plays a general role in targeting 
proteins that persistently associate with and potentially 
obstruct the translocon.
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Ravid et al., 2006; Scott and Schekman, 2008). As expected 
for a Doa10 substrate, Deg1-Sec62 is stabilized in cells lack-
ing both Ubc6 and Ubc7 (Mayer et al., 1998). Because elimi-
nating Ubc7 inactivates both Doa10 and Hrd1 pathways, 
however, it remained formally possible that Deg1-Sec62 is a 
Hrd1 substrate. We show that this is indeed the case and that 
aberrant engagement of the translocon by Deg1-Sec62 is respon-
sible for this E3 switch. This engagement triggers a topological 
Swanson et al., 2001). Besides soluble Deg1 fusions, we have 
fused Deg1 to the ER-resident TM protein Vma12 to study 
Doa10-dependent ERAD (Ravid et al., 2006). Deg1 has also 
been fused to the topologically similar ER protein Sec62 
(Mayer et al., 1998). Like Vma12, Sec62 has two TM seg-
ments, with both protein termini on the cytoplasmic side of the 
membrane (Deshaies and Schekman, 1990). Attachment of 
Deg1 destabilizes both Sec62 and Vma12 (Mayer et al., 1998; 
Figure 1. Deg1-Sec62 is a Hrd1 substrate. (A) Schematic diagram of Deg1 fusion proteins (with predicted topologies) used in this study. For each con-
struct, the N-terminal Deg1 is followed, in sequence, by the Flag (F) epitope, the 2-TM ER protein (Sec62 or Vma12), and two copies of the Protein A (PrA) 
tag. For clarity, the fusion proteins are referred to as Deg1-Sec62 or Deg1-Vma12. Any additional alterations to protein sequence will be noted. (B) Linear 
representation of Deg1-Sec62, drawn to scale. Positions of boundaries between elements within the fusion protein and residue numbers mentioned in the 
text are highlighted. (C) Pulse-chase analysis of Deg1-Vma12 in the indicated yeast strains. (D and F) Pulse-chase analysis of Deg1-Sec62 in the indicated 
yeast strains. Molecular weight markers for these autoradiographs are not available; however, migration of the same protein can be seen in Fig. 4 B. 
(E and G) Quantification of autoradiographs in D and F. Data are representative of three experiments. The black line indicates that intervening lanes have 
been spliced out. (H) Pulse-chase analysis of Deg1*-Sec62 in the indicated yeast strains. Deg1 fusions in C, D, and F were precipitated with anti-Deg1 
antibodies. Deg1*-Sec62 in H was precipitated with anti-Flag antibodies. Cycloheximide was included in the chase depicted in H. Deg1*, F18S/I22T 
double mutant.
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apparent exception to the division of ERAD-L/M and ERAD-C 
substrates between Hrd1 and Doa10, respectively (Vashist and 
Ng, 2004; Carvalho et al., 2006).
Doa10-mediated degradation of Deg1-harboring proteins 
depends on the hydrophobic face of a predicted amphipathic 
helix within Deg1 (Johnson et al., 1998). When mutations in 
this helix that stabilize Deg1-containing Doa10 substrates were 
introduced into Deg1-Sec62, the resultant protein (Deg1*-
Sec62) was still degraded in a Hrd1-dependent manner (Fig. 1 H), 
unlike Deg1*-Vma12, which is strongly stabilized (Ravid 
et al., 2006). Thus, the details underlying molecular recog-
nition of Deg1-containing substrates differ between the two 
ERAD E3s.
Posttranslational modification (PTM)  
of Deg1-Sec62
Deg1-Sec62 migrated as multiple species by SDS-PAGE and 
became increasingly modified with time after its synthesis 
(Fig. 1, D and F). It was previously noted that Deg1-Sec62 is 
N-glycosylated, in contrast to wild-type (WT) Sec62, which 
is not typically posttranslationally modified (Kim et al., 2006; 
Scott and Schekman, 2008). Immediately after radiolabeling, 
Deg1-Sec62 migrated as two distinct species (Fig. 2 A, lane 1). 
After treatment with Endoglycosidase H (Endo H), which re-
moves all N-glycans from yeast proteins, the slower-migrating 
band collapsed to the faster migrating species (lane 2). Mu-
tational analysis revealed that N153 was the major site of 
N-glycosylation (with a possible minor contribution by N90; 
lanes 5–12), which is consistent with an earlier study (Scott 
and Schekman, 2008). After 60 min, the higher mass species 
appeared as multiple diffuse bands (lane 3). Endo H treatment 
only partially increased the mobility of these poorly resolved 
bands (lane 4), which indicates additional PTM.
Deg1-Sec62 is also modified by O-mannosylation, an ER-
specific modification with a role in the ERAD of some Hrd1 
substrates (Vashist et al., 2001; Hirayama et al., 2008). We per-
formed pulse-chase analysis of doa10 hrd1 yeast expressing 
Deg1-Sec62-N90D/N153D cultured in the presence of a global 
change in Deg1-Sec62 that is closely associated with Hrd1-
dependent degradation.
We extended our investigation to a known cotranslo-
cationally degraded protein. Apolipoprotein B (apoB), the 
major protein component of low- and very-low-density lipo-
proteins, stalls in the translocon if it cannot associate with 
its lipid ligand and is subsequently degraded by the pro-
teasome (Yeung et al., 1996; Fisher et al., 1997; Pariyarath 
et al., 2001). We found that, like Deg1-Sec62, an apoB variant 
expressed in yeast that is also associated with the translocon 
(Hrizo et al., 2007) is targeted by the Hrd1 ubiquitin ligase. 
These results suggest that Hrd1 may play a general role in the 
degradation of proteins that aberrantly or persistently engage 
the translocon.
Results
Deg1-Sec62 is a Hrd1 substrate
We used pulse-chase analysis to examine the metabolic stabil-
ity of the ER-resident TM proteins Sec62 and Vma12 when 
the Deg1 degron was appended to their N termini (depicted 
in Fig. 1, A and B). Deg1 destabilized both proteins (Fig. 1, 
C and D). As previously demonstrated (Ravid et al., 2006), 
Deg1-Vma12 was strongly stabilized in cells lacking Doa10. 
It was also stabilized when either of the E2s that function with 
Doa10 (Ubc6 or Ubc7) were absent (Fig. 1 C). Unexpect-
edly, Deg1-Sec62 was only stabilized in the absence of Ubc7, 
which works with either Doa10 or Hrd1, but not in cells lack-
ing Ubc6, which functions exclusively in Doa10-dependent 
ERAD (Fig. 1, D and E).
We directly tested which ERAD E3s were responsible for 
Deg1-Sec62 degradation. Surprisingly, deletion of DOA10 did 
not impair Deg1-Sec62 degradation, whereas the Deg1 fusion 
protein was strongly stabilized in the absence of Hrd1 (Fig. 1, 
F and G). The Hrd1 dependence for Deg1-Sec62 degradation 
was unanticipated because Deg1 typically targets proteins to 
which it is fused for Doa10-dependent proteolysis. Moreover, 
the predicted cytoplasmic disposition of Deg1 represents an 
Figure 2. N-glycosylation of Deg1-Sec62.  
(A) doa10 hrd1 yeast cells expressing Deg1-
Sec62 or Deg1-Sec62 with the indicated con-
sensus N-glycosylation sites mutated were pulse 
labeled for 10 min and lysed immediately or 
after 60 min in the presence of excess nonradio-
active amino acids and cycloheximide. Deg1 
fusion proteins were precipitated with anti-Flag 
antibodies and incubated in the presence or 
absence of Endo H. (B) Pulse-chase analysis of 
Deg1-Sec62-N90D/N153D in the indicated 
yeast strains. Deg1-Sec62 was precipitated 
with anti-Flag antibodies. Cycloheximide was 
included in the chase.
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(Fig. 1, A and B) of Deg1-Sec62 remain on the cytoplas-
mic face of the ER membrane (Scott and Schekman, 2008). 
To confirm the cytoplasmic disposition of Deg1, ER-derived 
microsomal membranes were incubated with Proteinase 
K followed by anti-Deg1 immunoblotting (Fig. 3 A). The 
Deg1-dependent topological rearrangement that allows gly-
cosylation did not protect Deg1 from protease exposure to 
the external (cytoplasmic) face of microsomal membranes in 
the absence of detergent (lane 2). Cytoplasmic exposure of 
Deg1 is particularly intriguing given that Doa10 is incapable 
of targeting Deg1-Sec62.
The susceptibility of the Deg1-Sec62 N terminus to 
proteolysis despite ER luminal access of N153 could be ex-
plained in two ways. Deg1 fusion to Sec62 might stimulate 
stable movement of a portion of the normally cytoplasmic 
N-terminal domain downstream of Deg1 into the ER lumen. 
Alternatively, Deg1 attachment may allow reversible move-
ment of the entire N-terminal Deg1-Sec62 domain into and 
out of the ER lumen. Return of the N terminus to the cyto-
plasmic face of the ER would explain protease accessibility. 
Consistent with the first alternative, we found that micro-
somal Deg1-Sec62 was sensitive to Endo H only when deter-
gent was added (Fig. 3 B, lane 3). Therefore, fusion of Deg1 
to Sec62 triggers the stable movement of a portion of the 
N-terminal Sec62 tail into the ER lumen while Deg1 remains 
on the cytoplasmic side. These experiments are consistent 
with two models for the final topology of Deg1-Sec62, which 
differ in how much of the N-terminal domain is dislocated 
into the ER lumen (Fig. 3 C; see Discussion).
inhibitor of O-mannosylation (Orchard et al., 2004). Under 
these conditions, the more slowly migrating species of Deg1-
Sec62-N90D/N153D exhibited enhanced mobility but did not 
obtain the mobility of the fastest migrating, presumably un-
modified species (Fig. S1 A). The full complement of PTMs 
decorating Deg1-Sec62 and the substrate residues that they 
modify remain to be characterized.
Neither N-glycosylation nor O-mannosylation was re-
quired for Hrd1-mediated degradation of Deg1-Sec62 (Fig. 2 B 
and Fig. S1 B). Preventing glycosylation also did not re-
store Doa10-mediated targeting of Deg1-Sec62 (Fig. 2 B and 
Fig. S1 B). Conversely, N-glycosylation at engineered sites in 
Deg1-Vma12 did not prevent its Doa10-dependent degrada-
tion (Fig. S2 A). Nonetheless, Deg1-Sec62 PTMs serve as a 
convenient indicator of a topological transition that, as subse-
quent experiments will demonstrate, plays an important role 
in the switch from Doa10 to Hrd1 dependency.
Topology of Deg1-Sec62
Strikingly, N-glycosylation of Deg1-Sec62 occurred on resi-
dues in the predicted cytoplasmic N-terminal domain (Fig. 1 B), 
whereas the glycosylation machinery resides in the ER lumen. 
Therefore, fusion of Deg1 to Sec62 must stimulate dislocation 
of at least a portion of the cytoplasmically disposed N-terminal 
domain into the ER lumen. As judged by immunoblot analysis, 
the majority of Deg1-Sec62 at steady state was posttranslation-
ally modified, and therefore topologically altered (Fig. S1 C). 
Previous work indicated that both the Flag epitope immedi-
ately downstream of Deg1 and the C-terminal Protein A tag 
Figure 3. Membrane topology of Deg1-Sec62. (A) Intact microsomal membranes prepared from doa10 hrd1 cells expressing Deg1-Sec62 and ER 
luminal control protein CPY* were treated with 5 µg/ml Proteinase K (or mock-treated) in the presence or absence of 1% Triton X-100. Samples were sepa-
rated by SDS-PAGE and detected by immunoblotting with antibodies against Deg1 (top) or CPY (bottom). Diamonds denote nonspecific bands. Partially 
protease-resistant, anti–Deg1-reactive species are seen between 37 and 50 kD when detergent is excluded (lane 2). Species of similar size and intensity are 
observed when Deg1-Vma12 is subjected to the same treatment (Fig. S3, lane 8). Thus, the Deg1 moiety of Deg1-Sec62 exhibits protease accessibility 
similar to that of Deg1-Vma12. (B) The same as in A, but microsomal preparations were incubated with Endo H instead of Proteinase K. Deg1-Sec62 was 
detected by immunoblotting with peroxidase anti-peroxidase antibody, which recognizes the Protein A epitope. (C) Models for topological rearrangement 
of Deg1-Sec62 with respect to the ER membrane. In each case, both N-terminal Deg1 and C-terminal Sec62 tail remain on the cytoplasmic face of the 
ER membrane. In the 4-TM model, the normally cytoplasmic sequence of Deg1-Sec62 downstream of Deg1 loops into the ER lumen, flanked by two novel 
membrane-spanning segments. In the 2-TM model, the first membrane-spanning segment of Deg1-Sec62 is significantly upstream of the first normally used 
Sec62 TM. The approximate position of the N-glycosylated N153 residue is indicated with a cartoon representation of the N-glycan.
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in doa10 cells and remained unstable in hrd1 cells. Full 
metabolic stabilization was not observed unless both E3s were 
absent, which is consistent with the incomplete ablation of 
sec62† interaction with Sec63 (Wittke et al., 2000).
The dramatically reduced Hrd1 dependence of Deg1-
sec62† degradation coincided with significantly delayed gly-
cosylation (which requires topological rearrangement of the 
Sec62 N-terminal domain), which suggested a mechanistic link 
between the two (Fig. 4 A, compare doa10 hrd1 cells, top 
and bottom panels; and Fig. S1 D). The remaining trace of post-
translationally modified Deg1-sec62† was stabilized in hrd1 
cells (Fig. 4 A). As with the Deg1-sec62† mutant, the sec63-201 
mutant, which interacts poorly with WT Sec62 (Ng and Walter, 
1996; Wittke et al., 2000), caused an increase in the degrada-
tion rate, a switch in E3 specificity, and a delay in modifica-
tion of Deg1-Sec62 (Fig. 4 B). Complementation of sec63-201 
cells with WT SEC63 caused all these changes to be reverted 
(Fig. 4 C). When the sec62† mutation was introduced in the con-
text of Deg1*, which is not recognized by Doa10, the protein 
was almost completely stabilized (Fig. 4 D). These data strongly 
suggest that persistent interaction of Deg1-Sec62 with the trans-
locon stimulates both Deg1-Sec62 domain dislocation into the 
ER lumen and its switch to Hrd1-dependent degradation.
Impaired translocon binding to Deg1-Sec62 
allows Doa10-dependent degradation
Based on genetic and physical interactions, Sec61 has been 
proposed to function as a retrotranslocation channel for Hrd1 
substrates, although this remains controversial (de Virgilio 
et al., 1998; Willer et al., 2008; Schäfer and Wolf, 2009). Sec62 
is a component of the Sec61 complex involved in posttrans-
lational translocation (PTT; Deshaies et al., 1991; Ng et al., 
1996). In a strain background that limits its degradation, Deg1-
Sec62 complements sec62 mutants, which suggests that it as-
sociates with Sec61 in a manner similar to WT Sec62 (Mayer 
et al., 1998). We hypothesized that recognition of Deg1-Sec62 as 
a Hrd1 substrate is mediated by its incorporation into the trans-
locon complex. To test this, we introduced a point mutation into 
Deg1-Sec62 (G127D, Deg1-sec62†) that partially impairs Sec62 
association with Sec63, its interacting partner within the trans-
locon complex (Deshaies and Schekman, 1990; Deshaies et al., 
1991; Wittke et al., 2000), and assayed protein degradation.
Deg1-sec62† exhibited a shorter half-life than Deg1-
Sec62 (Fig. 4 A, compare WT cells, top and bottom). Strik-
ingly, this single point mutation directed a switch in the E3 
dependence of degradation (Fig. 4 A, top). Unlike Deg1-Sec62, 
Deg1-sec62† was strongly (though incompletely) stabilized 
Figure 4. Inhibiting Deg1-Sec62 association with the 
translocon delays its PTM and restores Doa10-dependent 
degradation. (A–D) Pulse-chase analysis of Deg1-Sec62 
variants in the indicated yeast strains. Where noted, yeast 
harbor a plasmid encoding WT Sec63 or an empty vector. 
Deg1 fusions in A and D were precipitated with anti-Deg1 
antibodies. Deg1 fusions in B and C were chased in the 
presence of cycloheximide and precipitated with anti-Flag 
antibodies. Molecular weight markers for the autoradio-
graph in A are not available; however, migration of the 
same protein can be seen in Fig. S1 D. sec62†, G127D 
of Deg1-Sec62, equivalent to G37D of untagged Sec62. 
sec63-201, 27-residue C-terminal truncation of Sec63. 
Deg1*, F18S/I22T double mutant.
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The gradually appearing, posttranslationally modified species 
of Deg1-Sec62 were cleared in a Hrd1-dependent manner. 
A similar delay in PTM and reversion to Doa10-dependent deg-
radation were observed in cells lacking the BiP co-chaperone 
Lhs1, which is required for efficient PTT of many proteins 
(Fig. 5 B; Hamilton et al., 1999; Tyson and Stirling, 2000; Steel 
et al., 2004). Passage of a portion of Deg1-Sec62 through the 
translocon is consistent with the reported formation of a tran-
sient disulfide linkage between a cysteine within the channel 
interior of Sec61 and a cysteine in the N-terminal domain of 
Deg1-Sec62 (but not WT Sec62; Scott and Schekman, 2008). 
Indeed, mutating either participating cysteine accelerated Deg1-
Sec62 degradation and partially switched E3 dependence from 
Hrd1 to Doa10 (Fig. 5, C and D).
In summary, these data strongly suggest that topological 
rearrangement of Deg1-Sec62 takes place through the Sec61 
translocon by a PTT mechanism and that this is necessary for 
Hrd1 recognition.
Degradation of Deg1-Sec62 differs from 
that of previously characterized ERAD-L 
and ERAD-M substrates
Deg1-Sec62 domain dislocation moves normally cytoplasmic 
residues of Sec62 to the ER lumen and membrane. We therefore 
determined if Deg1*-Sec62 degradation requires Hrd1 cofac-
tors required for ERAD-L and ERAD-M substrate degradation. 
Topological rearrangement of Deg1-Sec62 
via PTT
Most N-glycosylated proteins are modified while they are being 
translocated (Whitley et al., 1996; Popov et al., 1997; Scheper 
et al., 2003). Like WT Sec62, Deg1-Sec62 is likely cotransla-
tionally translocated into the ER membrane. The gradual acqui-
sition of N-glycosylation, especially when translocon binding 
is partially impaired (Fig. 4 and Fig. S1 D), suggested that the 
topological transition allowing such modification occurs after 
the initial “normal” membrane insertion, possibly through the 
Sec61 channel itself. We hypothesized that appending Deg1 
to Sec62 triggers insertion of a portion of the cytoplasmic 
N-terminal domain through the Sec61 translocon via a PTT 
mechanism after initial cotranslational translocation of Deg1-
Sec62 (Zimmermann et al., 2011). Moreover, we speculated 
that this insertion is critical for triggering Hrd1-dependent deg-
radation and preventing Doa10 recognition of Deg1-Sec62.
To test these ideas, we analyzed Deg1-Sec62 E3 specific-
ity and PTM kinetics in cells expressing a variant of Sec61—
sec61-L7B(ala)—which harbors four mutations in a luminal 
loop and is predominantly defective for PTT (Trueman et al., 
2011). Strikingly, in the context of sec61-L7B(ala), Deg1-
Sec62 degradation reverted to Doa10 dependence (Fig. 5 A). 
A delay in PTM coincided with impaired degradation in doa10 
cells expressing sec61-L7B(ala), likely signifying delayed 
movement of the Sec62 N-terminal domain into the ER lumen. 
Figure 5. Deg1-Sec62 topological rearrangement and Hrd1 
targeting depend on the PTT pathway. (A–D) Pulse-chase analy-
sis of denoted Deg1-Sec62 variants in the indicated yeast 
strains. Where noted, yeast harbor a plasmid encoding a vari-
ant of Sec61. Cycloheximide was included in the chase. Deg1 
fusion proteins were precipitated with anti-Flag antibodies.
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mammalian ERAD components, including HRD1, Derlin-1, 
and p97 (Fisher et al., 2008; Rutledge et al., 2009). Moreover, 
overexpression of the mammalian E3 gp78 (a HRD1 paralogue) 
stimulates degradation of apoB (Liang et al., 2003). Knock-
down of gp78 expression decreases apoB ubiquitylation and 
enhances apoB secretion (Fisher et al., 2011). A model apoB 
derivative (apoB29) expressed in yeast copurifies with the 
translocon and is partially stabilized in ubc7 or doa10 hrd1  
cells but not ubc6 cells, which is consistent with a wider 
role for Hrd1 in degradation of proteins persistently associ-
ated with the translocon (Hrizo et al., 2007). We therefore per-
formed cycloheximide-chase/immunoblot analysis to test directly 
whether apoB29 degradation requires this E3. ApoB29 was in 
fact significantly stabilized in hrd1 cells (Fig. 7 A).
ApoB29 appeared as multiple bands when separated 
by SDS-PAGE, with a gradual conversion of lower to higher 
molecular weight species over time. This is most apparent 
under stabilizing conditions (i.e., in hrd1 cells). ApoB29 
is a translocon-engaged protein with its N terminus exposed 
to the ER lumen. These slower migrating bands of apoB29 
were sensitive to Endo H, which indicates N-glycosylation of 
apoB29 (Fig. 7 B). A complete collapse to the fastest migrat-
ing species was not observed, however, which suggests that 
apoB29, like Deg1-Sec62, acquires additional PTMs distinct 
from N-glycosylation. These additional PTMs became more 
prominent after inhibition of protein synthesis, as has previ-
ously been observed for other ERAD substrates (Wilhovsky 
et al., 2000; Sato and Hampton, 2006).
Finally, we analyzed the cofactor requirements for apoB29 
degradation. In contrast to Deg1-Sec62, apoB29 was markedly sta-
bilized in cells lacking Hrd3, Yos9, Usa1, or the Derlins (Fig. 7 C). 
Thus, although both proteins may be targeted by Hrd1 by virtue of 
their aberrant or prolonged translocon engagement, they differ with 
respect to the exact cofactors required for their degradation.
Discussion
Many proteins pass through the Sec61 translocon en route 
to their ultimate subcellular or extracellular destinations. 
Deg1*-Sec62 was efficiently degraded in the absence of 
Yos9 and the Derlins (Der1 and Dfm1), proteins with roles in 
ERAD-L, and only marginally stabilized in the absence of Usa1, 
which functions in both ERAD-L and ERAD-M (Fig. 6 A; 
Knop et al., 1996; Buschhorn et al., 2004; Bhamidipati et al., 
2005; Kim et al., 2005; Szathmary et al., 2005; Carvalho 
et al., 2006; Goder et al., 2008; Horn et al., 2009; Carroll and 
Hampton, 2010; Carvalho et al., 2010; Kanehara et al., 2010). 
Deg1*-Sec62 was significantly, but incompletely, stabilized 
in the absence of Hrd3, which is required for degradation of 
both ERAD-L and ERAD-M substrates (Hampton et al., 1996; 
Carvalho et al., 2006; Gauss et al., 2006). However, this effect 
may be indirect, as Hrd1 levels are markedly reduced in the 
absence of Hrd3 (Plemper et al., 1999). A control ERAD-L 
substrate, CPY*-HA, was significantly stabilized in these mutant 
strains (Fig. 6 B). Degradation requirements for Deg1*-Sec62 
bear some resemblance to those for the ERAD-M substrate 
Hmg2. However, Hmg2 degradation displays a stronger de-
pendence on Hrd3 (Wilhovsky et al., 2000) and potentially 
Usa1 (Horn et al., 2009; Carroll and Hampton, 2010) for its 
degradation. Together, these results suggest that recognition 
of Deg1-Sec62 occurs through a novel mechanism requiring 
the minimal ERAD machinery consisting of Hrd1, Ubc7, pre-
sumably Cue1 (which anchors Ubc7 to the ER membrane), 
and possibly Hrd3. Novel cofactors might also be involved.
Degradation of an apolipoprotein  
B derivative requires Hrd1
We hypothesized that the mechanism used by Hrd1 to target 
Deg1-Sec62 at the translocon may be related to that of a known 
cotranslocationally degraded protein with intriguing links to 
human health. Under conditions in which lipid binding of apoB 
(a major component of low-density and very-low-density lipo-
proteins) is impaired, apoB translocation is arrested and the 
protein remains associated with the translocon (Fisher et al., 
1997; Pariyarath et al., 2001). Incompletely translocated apoB 
is redirected to proteasomal degradation in the cytoplasm 
(Yeung et al., 1996), perhaps via a mechanism similar to that 
of Deg1-Sec62 degradation. ApoB copurifies with several 
Figure 6. Hrd1 cofactor requirements for Deg1-Sec62 degra-
dation. (A) Pulse-chase analysis of Deg1*-Sec62 in the indicated 
yeast strains. The percentage of input protein remaining at each 
time-point is indicated below the autoradiograph. Cyclohexi-
mide was included in the chase. Deg1*-Sec62 was precipitated 
with anti-Flag antibodies. Deg1*, F18S/I22T double mutant. 
The black line indicates that intervening lanes have been spliced 
out. (B) Cycloheximide chase analysis of CPY*-HA in the indi-
cated yeast strains. CPY*-HA was detected by anti-HA immuno-
blotting. Pgk1 serves as a loading control and was detected by 
anti-Pgk1 immunoblotting.
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Although glycosylation is not required for Hrd1-mediated 
degradation, the switch in degradation dependence from 
Doa10 to Hrd1 tracks very closely with acquisition of these 
PTMs. Our data strongly suggest that the topological rear-
rangement across the ER membrane is the crucial event dic-
tating E3 specificity (Fig. 8).
Other work supports the 4-TM model of rearranged 
topology (Fig. 3 C). Potential O-mannosylation sites (serines) 
were systematically introduced throughout Deg1-Sec62 (Scott 
and Schekman, 2008). We inferred that residues that became 
O-mannosylated reached the ER lumen; nonmodified serine 
substitutions were judged to be in the membrane-spanning or 
cytoplasmic segments. O-mannosylation of serines inserted 
at positions 132 and 170 confirmed that this span is pres-
ent within the ER lumen (see Fig. 1 B). Substitutions at other 
positions, such as immediately upstream of the first known 
TM, did not result in O-mannosylation. The most straightfor-
ward interpretation of these data is the 4-TM model of Deg1-
stimulated topological rearrangement (Fig. 3 C), although the 
failure to observe O-mannosylation of a particular serine does 
not exclude its luminal residence (Lommel and Strahl, 2009).
Potentially, ERAD substrates may also pass through this chan-
nel in a retrograde fashion en route to proteasomal degrada-
tion. Aberrant, translocationally stalled proteins might limit 
flux through the channel in either direction, and eukaryotes 
may therefore have evolved mechanisms for eliminating such 
obstructions. Although Deg1-Sec62 (like many heavily stud-
ied model ERAD substrates) is an artificial protein, it may 
illuminate a previously unappreciated protein quality-control 
pathway mediated by the Hrd1 ubiquitin ligase and serve as a 
prototype for proteins that aberrantly engage or occupy the 
translocon. Indeed, we find that clearance of apoB, a protein 
previously reported to be cotranslocationally degraded, also 
depends on Hrd1.
Deg1-Sec62 inserts into the ER membrane in two dis-
tinct steps. Initially, the two TM segments of Deg1-Sec62 
are probably cotranslationally translocated to yield the same 
topology as WT Sec62. In a second, Deg1-dependent step, 
a loop within the normally cytoplasmic N-terminal domain 
of Deg1-Sec62 penetrates the ER membrane. This rearrange-
ment allows access of previously cytoplasmic residues to 
the N- and O-glycosylation machinery of the ER lumen. 
Figure 7. ApoB29 is a Hrd1 substrate. (A–C) Cycloheximide chase analysis of ApoB29-3HA, expressed under the control of the GAL1 promoter in the 
indicated yeast strains, which were grown for 5 h in SD medium containing 2% galactose. ApoB29-3HA was detected by anti-HA immunoblotting. Pgk1 
serves as a loading control and was detected by anti-Pgk1 immunoblotting. The diamonds denote a nonspecific band. (A) As controls, hrd1 yeast harbor-
ing a plasmid with GAL1-driven ApoB29-3HA were grown in 2% glucose (repressing) medium, and hrd1 yeast harboring an empty vector were grown 
in 2% glucose (repressing) or 2% galactose (inducing) medium and processed similarly. (B) Lysates prepared immediately or 90 min after cycloheximide 
addition were incubated in the presence or absence of Endo H.
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Lateral release of true TM segments from the translocon 
into the plane of the lipid bilayer depends strongly on the hy-
drophobic character of the TM helices (Shao and Hegde, 2011; 
Zimmermann et al., 2011). The N-terminal loop of Deg1-Sec62 
does not include bona fide TM domains; thus, we speculate 
that the membrane-spanning polypeptide segments flanking 
the N-glycosylated luminal element resist lateral release from 
the translocon and persistently occupy the Sec61 channel. We 
propose that Hrd1 recognizes persistent translocon engage-
ment by Deg1-Sec62 after the aberrant translocation event. 
In this respect, Deg1-Sec62 may resemble a translocationally 
stalled or arrested protein. Hrd1, by virtue of its reported as-
sociation with the translocon (Schäfer and Wolf, 2009), may be 
ideally poised to target such incompletely translocated proteins 
for ubiquitin-mediated degradation. It is also possible that the 
Sec61-dependent topological change in Deg1-Sec62 generates 
a permanently misfolded TM protein or misassembled trans-
locon complex that is recognized by Hrd1. Nevertheless, the 
cofactor requirements for Deg1-Sec62 differ from other well-
characterized Hrd1 substrates (Fig. 8), which is consistent with 
a unique mechanism for recognition and degradation.
Deg1 has been found to destabilize other TM proteins in 
a partially Hrd1-dependent manner. Like Deg1-Sec62, both 
Deg1-Hmg1 and Deg1-Hmg2 fusion proteins are strongly sta-
bilized in the absence of Ubc7. Deletion of HRD1 partially 
impairs turnover of these proteasome substrates (Wilhovsky 
et al., 2000). Whether these proteins are targeted in a mechanism 
similar to that targeting Deg1-Sec62 remains to be determined.
The factors preventing Doa10 from recognizing Deg1-
Sec62 remain enigmatic. After topological rearrangement 
of Deg1-Sec62, Deg1 remains on the cytoplasmic face of 
the ER membrane (Fig. 3). However, this posttranslationally 
translocated form of the fusion protein is resistant to Doa10-
mediated proteolysis. The translocon-dependent rearrangement 
might alter the position or conformation of Deg1 such that it is 
inaccessible to the Doa10 complex. Preventing interaction of 
Deg1-Sec62 with the translocon causes a strong reversion to 
Topological rearrangement of Deg1-Sec62 likely occurs 
via Sec61-mediated PTT. Disrupting contacts of Deg1-Sec62 
with the translocon or impairing PTT by Sec61 mutation pre-
vents domain dislocation and significantly reverts degradation 
dependence to Doa10 (Figs. 4 and 5). Additionally, a cysteine 
found within the initially cytoplasmic N-terminal domain of 
Deg1-Sec62 forms a transient disulfide linkage with a cysteine 
on the interior of the Sec61 channel (Scott and Schekman, 
2008). This bond appears to facilitate the altered topology of the 
Sec62 N-terminal domain, as mutation of either participating 
cysteine delays Deg1-Sec62 PTM and causes a partial switch 
to Doa10-dependent degradation (Fig. 5, C and D).
Fusion of Deg1 to Sec62 was not anticipated to trigger 
PTT of the normally cytoplasmic Sec62 N-terminal domain. 
MAT2, from which Deg1 is derived, is a soluble nuclear pro-
tein, and Deg1 fused to the isolated soluble Sec62 N-domain 
(residues 1–149) does not trigger membrane translocation 
(Scott and Schekman, 2008). Rather, Deg1-Sec621–149 is de-
graded in a Doa10-dependent manner, behaving like other 
characterized soluble Deg1 fusions (Fig. S2 B). Potentially, 
fusing any protein sequence to the Sec62 N terminus could 
promote the observed topological rearrangement. This is not 
the case, however, as Deg1 bearing a 20-residue internal dele-
tion does not promote PTM (or degradation) when fused to 
Sec62 (Scott and Schekman, 2008). Deg1, by virtue of novel 
protein–protein and/or protein–membrane interactions stimu-
lated by enforced proximity to the translocon, may conforma-
tionally alter the N-terminal portion of Sec62 or cause it to 
linger persistently near the opening of the Sec61 translocon 
channel. The translocon could respond by attempting to con-
duct the Sec62 N-terminal tail into the ER lumen. The disul-
fide linkage between Deg1-Sec62 and the Sec61 channel may 
strengthen the interaction of the Sec62 N-domain with a signal 
sequence-binding site within the channel. Consistent with this, 
the cysteine cross-link is not strictly necessary for topological 
rearrangement but significantly accelerates it (Fig. 5, C and D; 
and Fig. S1 D).
Figure 8. Model for Hrd1-dependent ERAD of Deg1-Sec62. (A) After its initial cotranslational translocation, Deg1-Sec62 aberrantly engages the Sec61 
translocon, resulting in PTT of the normally cytoplasmic N-terminal Sec62 tail. After membrane penetration, Deg1-Sec62 becomes N-glycosylated. In this 
rearranged conformation, Doa10 does not recognize Deg1-Sec62 as an ERAD-C substrate. Deg1-Sec62 remains trapped in this orientation unless Hrd1 
targets it for degradation, thereby restoring functionality to the Sec61 translocon. With the exception of the E2 Ubc7 (and presumably its membrane-
anchoring binding partner Cue1; Biederer et al., 1997), and potentially Hrd3 (not depicted), well-characterized Hrd1 cofactors that function in ERAD-L and 
ERAD-M are dispensable for ERAD of Deg1-Sec62. The approximate position of N-glycosylated N153 residue is indicated with a cartoon representation 
of the N-glycan. (B) When translocon engagement is prevented by disrupting Deg1-Sec62 interaction with the translocon or impairing PTT, Deg1-Sec62 
retains its original topology and is targeted by Doa10 as an ERAD-C substrate. Black circles, ubiquitin.
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process provisionally called ERAD-T (for “translocon associ-
ated”). ERAD-T substrates may include proteins that aberrantly 
stall in the translocon either because of an abnormality in the 
translocating protein (such as may be the case for Deg1-Sec62) 
or because of malfunction in the translocation process itself. 
Such substrates may be difficult to identify experimentally, 
as they likely represent a small subpopulation of any given 
translocated gene product. Artificial translocon-occupying 
substrates, such as Deg1-Sec62, may serve as a model for un-
derstanding such mechanisms. Other cellular pathways may 
have co-opted this quality-control pathway to mediate the 
regulated destruction of otherwise normal proteins. The low-
density and very-low-density lipoprotein biosynthesis path-
way provides a likely example of a protein—apoB—whose 
regulated degradation utilizes a basic cellular quality control 
mechanism. Future studies will seek to understand the mecha-
nisms by which Hrd1 recognizes this potentially distinct class 
of substrates that persistently engage the translocon.
Materials and methods
Yeast and bacterial methods
With the exception of cells prepared for cycloheximide chase/immunoblot 
analysis of apoB29, yeast were grown in synthetic defined (SD) medium 
that was prepared as described previously (Guthrie and Fink, 1991). For 
experiments involving apoB29, yeast cells were cultured in modified SD 
medium with 5 mg/ml of acid-hydrolyzed casein and 0.08 mg/ml tryp-
tophan as the amino acid source. Standard techniques were used for ge-
netic manipulation of yeast strains (Guthrie and Fink, 1991). To introduce 
gene deletions, selection markers were PCR-amplified from donor strains 
with flanking sequences containing homology upstream and downstream 
of target gene start and stop codons. PCR products were transformed into 
yeast to replace genes by homologous recombination. Gene disruptions 
were confirmed by PCR. Standard techniques were used for plasmid ma-
nipulation in Escherichia coli (Ausubel et al., 1989). Site-directed muta-
genesis was used to introduce point mutations (Zheng et al., 2004). Yeast 
strains and plasmids used in this study are presented in Tables S1 and S2, 
respectively. Yeast strains and plasmids not constructed in our labora-
tory were provided by C. Andreasson (Stockholm University, Stockholm, 
Sweden), J. Brodsky (University of Pittsburgh, Pittsburgh, PA), E. Craig 
(University of Wisconsin, Madison, Madison, WI), R. Gilmore (University 
of Massachusetts Medical School, Boston, MA), Y. Jigami (National Insti-
tute for Advanced Industrial Science and Technology, Tsukuba, Japan), 
N. Johnsson (Ulm University, Ulm, Germany), D. Ng (National Univer-
sity of Singapore, Singapore), R. Schekman (University of California, 
Berkeley, Berkeley, CA), D. Scott (St. Jude Children’s Research Hospital, 
Memphis, TN), and T. Yoko-o (National Institute for Advanced Industrial 
Science and Technology, Tsukuba, Japan).
Pulse-chase analysis
Pulse-chase analysis was performed essentially as described previously 
(Chen et al., 1993). Yeast cells were labeled with 20 µCi TRAN35S-LABEL 
(MP Biomedicals) per 1 OD600 unit of cells at 30°C for 10 min in SD me-
dium lacking methionine and cysteine. Chases with excess unlabeled Met 
and Cys were performed in the absence of cycloheximide, except where 
noted in the figure legends. Inclusion of 500 µg/ml cycloheximide had no 
detectable impact on degradation kinetics, modification kinetics, or E3 
specificity. Immunoprecipitation of Deg1 fusion proteins was performed 
with anti-FLAG M2 affinity resin (Sigma-Aldrich) or sequential incubation 
with anti-Deg1 antibody (Hochstrasser and Varshavsky, 1990) and aga-
rose cross-linked to recombinant Protein A (Repligen), as indicated in the 
figure legends. Immunoprecipitated proteins were separated by SDS-PAGE 
and analyzed by autoradiography, using a Storm 860 Phosphorimager sys-
tem and ImageQuant 5.2 software (Molecular Dynamics).
Cycloheximide chase and standard immunoblot analyses
Cycloheximide was added to a final concentration of 250 µg/ml to loga-
rithmically growing cells. For analysis of CPY*-HA, cells were lysed es-
sentially as described by Kushnirov (2000). 2.5 OD600 units of cells were 
Doa10-dependent degradation (Fig. 4). Therefore, Deg1-Sec62 
is not inherently unrecognizable by Doa10. Interfering with 
events downstream of translocon binding (e.g., inhibiting PTT 
or preventing Deg1-Sec62–Sec61 disulfide formation) also 
causes a significant switch to Doa10-dependent degradation 
(Fig. 5). Thus, Doa10 is capable of recognizing Deg1-Sec62 
even when conditions allow initial interaction with the trans-
locon. In these cases, Doa10 might target Deg1-Sec62 that is 
in complex with the translocon but has not yet undergone PTT 
or might recognize Deg1-Sec62 that has transiently dissociated 
from Sec61.
The discovery that abnormal translocon engagement 
precedes Deg1-Sec62 degradation led us to hypothesize that 
cotranslocational proteolysis of apoB might occur by a similar 
mechanism. ApoB uses the translocon as a platform for pro-
gressive lipid binding. When lipid binding is inhibited, translo-
cation into the ER lumen is slowed, and the protein is destroyed 
by the cytoplasmic proteasome (Fisher et al., 1997; Pariyarath 
et al., 2001). Earlier studies implied that degradation of a model 
variant of apoB occurred via the ERAD system in yeast (Hrizo 
et al., 2007). Our results directly demonstrate Hrd1 dependence 
for apoB29 degradation in yeast (Fig. 7 A). The cofactor re-
quirements for Deg1-Sec62 and apoB Hrd1-dependent degra-
dation, however, differed, which suggests that the details of 
E3-substrate recognition diverge for these substrates.
A previous study had led to the suggestion that Deg1-
Sec62 glycosylation and disulfide formation with Sec61 occur 
during Sec61-dependent retrotranslocation of a Doa10 substrate 
(Scott and Schekman, 2008). Our results, however, strongly 
suggest that these events occur in the process of Hrd1 substrate 
generation. Given the general dependence of substrate ret-
rotranslocation upon functional ubiquitin conjugation machin-
ery (Biederer et al., 1997; de Virgilio et al., 1998), N-glycosylation 
of Deg1-Sec62 in doa10 hrd1 cells (Fig. 2 A) indicates that 
such modification happens upstream of substrate selection. The 
disulfide cross-link between Deg1-Sec62 and Sec61 was inter-
preted as representing a briefly stalled retrotranslocation inter-
mediate, as preventing this disulfide from forming accelerated 
degradation. However, we found that the increased degradation 
rate of Deg1-Sec62 in the absence of the disulfide linkage is 
caused by a switch from Hrd1-dependent degradation to com-
paratively rapid Doa10-mediated proteolysis (Fig. 5, C and D). 
Therefore, although our data establish a role for Sec61 in the 
biogenesis of a Hrd1 substrate, they do not directly implicate 
Sec61 as a retrotranslocon for Deg1-Sec62, although this re-
mains possible. It is tempting to speculate that, in a manner mir-
roring its membrane insertion, retrotranslocation of Deg1-Sec62 
occurs in two steps: extraction of the aberrantly rearranged por-
tion from the Sec61 channel followed by removal of the normal 
TM segments, potentially also through Sec61. Similarly, the 
precise mechanism by which apoB is extracted from the ER 
membrane remains to be elucidated. Translocationally stalled 
apoB might simply be extruded back into the cytoplasm via ret-
rograde transport through the translocon in which it stalls, or it 
might be transferred to another retrotranslocating complex.
We speculate that Hrd1 may play an important role in 
removing proteins that persistently engage the translocon in a 
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phosphate, pH 7.5, 150 mM NaCl, and 2 mM dithiothreitol). Cells were 
digested in 140 µg zymolyase 100T (MP Biomedicals)/10 OD600 units of 
cells in spheroplast buffer for 20 min at 30°C. Spheroplasts were har-
vested by centrifugation (5 min at 600 g at 4°C) and washed in sphero-
plast buffer containing 20 µg/ml pepstatin A and 1 mM EDTA (for 
samples destined for protease protection analysis) or spheroplast buffer 
containing 1× EDTA-free Complete Protease Inhibitor Cocktail (Roche) 
and 1 mM EDTA (for samples destined for Endo H protection analysis). 
Spheroplasts were centrifuged again (5 min at 600 g at 4°C) and resus-
pended in fractionation buffer (200 mM d-mannitol, 20 mM sodium phos-
phate, pH 7.5, and 150 mM NaCl) containing appropriate protease 
inhibitors and lysed by vortexing in the presence of glass beads for three 
30-s pulses with 1 min on ice between pulses. Unbroken cells and cellular 
debris were centrifuged (5 min at 600 g at 4°C), and the supernatant 
was used as the microsomal preparation. For Proteinase K protection ex-
periments, microsome preparations corresponding to 3.75 OD600 units 
were incubated with or without 1% Triton X-100 and treated with Protein-
ase K (Roche) in storage buffer (20 mM Tris, pH 7.5, 1 mM CaCl2, and 
50% glycerol) at a final concentration of 5 µg/ml or mock-treated with 
storage buffer alone. Reactions were performed on ice for 30 min. Pro-
teinase K activity was quenched with 10 mM PMSF. For Endo H protec-
tion experiments, microsome preparations corresponding to 3.75 OD600 
units were supplemented with potassium acetate, pH 5.6, to a final con-
centration of 80 mM. Samples were incubated with or without 1% Triton 
X-100 and treated with 0.004 U Endo H or mock-treated with water. Re-
actions were performed at 37°C for 2 h with gentle mixing every 20–30 min. 
Reactions were terminated with ice-cold TCA added to a final concentra-
tion of 10%.
For both Proteinase K and Endo H protection experiments, proteins 
were precipitated with 10% ice-cold TCA. Proteins were pelleted by cen-
trifugation at 4°C. Pellets were washed with 2% TCA and resuspended in 
50 µl TCA sample buffer (Loayza and Michaelis, 1998). Acidic samples 
(which caused the bromophenol blue indicator to turn yellow) were neutral-
ized, and samples were boiled for 8 min.
Inhibition of O-mannosylation
Yeast cells were cultured for 3 h at 30°C in the presence of 1 µM 
5-[[3-(1-phenylethoxy)-4-(2-phenylethoxy)phenyl]methylene]-4-oxo-2-thioxo-
3-thiazolidineacetic acid (“Compound 5a”; Biotrend Chemicals; Orchard 
et al., 2004), provided by S. Strahl (University of Heidelberg, Heidelberg, 
Germany), a global inhibitor of O-mannosylation in S. cerevisiae (Strahl, 
S., personal communication; Arroyo et al., 2011).
Online supplemental material
Fig. S1 shows PTM of Deg1-Sec62. Fig. S2 shows Doa10-dependent 
degradation of Deg1 fusion proteins. Fig. S3 shows membrane topol-
ogy of Deg1-Sec62, Deg1-sec62†, and Deg1-Vma12. Table S1 shows 
yeast strains used in this study. Table S2 shows plasmids used in this 
study. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.201203061/DC1.
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